Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Pharmacy business

Boots sees profits fall by a fifth in 2018

Boots has reported an almost 20% decline in its 2018 profits compared to the previous year, according to its latest accounts filing.

The accounts, filed to Companies House and published on 10 May 2019, show that the multiple pharmacy earned £317m in profit in 2018, compared with £388m in 2017 — a fall of 18.3%. Revenue also declined by 2.3% year-on-year to £6.8bn in 2018.

Walgreens Boots Alliance, Boots’s parent company, already reported a 23% decline in income over the past year in April 2019, and suggested it would be looking into “consolidation” of low-performing stores in the UK as a result.

According to the latest accounts report from Boots, its “pharmacy sales, gross profit and gross profit margin are impacted by governmental agencies seeking to minimise increases in the costs of healthcare, including pharmaceutical drug reimbursement rates”.

“The amount of government funding available for pharmacy services is typically reviewed and agreed with the pharmacy industry on an annual basis,” it added.

Data published in March 2019 revealed that the Department of Health and Social Care had halved its expenditure on generics price concessions compared with the previous year, with pharmacists saying the cut costs were leaving the profession “in a dreadful position”.

The 2018/2019 financial year has proved to be challenging for many multiples, with McKesson, LloydsPharmacy’s parent company, warning of “further closures” to its European pharmacies.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206537

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.